Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Difule Biological Technology is a biotechnology company based in China that specializes in the development and production of in vitro diagnostic (IVD) solutions. The company's core expertise lies in molecular diagnostics, offering a comprehensive portfolio that includes nucleic acid extraction systems, PCR detection kits, and specimen collection tools. Difule gained significant prominence for its rapid response during the COVID-19 pandemic, providing high-quality virus sampling tubes and extraction reagents globally. Their products are designed for clinical diagnostics, disease control, and laboratory research applications. The company operates from a modern manufacturing facility in Huzhou, adhering to international quality standards for medical device production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Difule Biological.